Home › Beryllium Develops An MCL-1 Platform For Structure-Guided Drug Discovery In Collaboration With The Broad Institute
 

Keywords :   


Beryllium Develops An MCL-1 Platform For Structure-Guided Drug Discovery In Collaboration With The Broad Institute

2015-06-03 06:25:44| drugdiscoveryonline Home Page

Beryllium, a scientific research services company engaging in collaborations with commercial and academic partners, recently announced the development of an MCL-1 platform for structure-guided drug discovery

Tags: the institute drug broad

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11
23.11 WEEZER / maladroit 12\"
23.11
23.11 6'1ML REV-S
23.11speak up storys
23.11190mm LS0713FL
23.11That's Moulton
23.11SEED
More »